(Q30654880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

Linking structural, metabolic and functional changes in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M Filippi

series ordinal

1

1 reference

26 June 2017

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

291-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

Pathology of multiple sclerosis: progression of the lesion

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

The distribution of plaques in the cerebrum in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

How does brain MRI lesion volume change on serial scans in patients with multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Whole brain volume changes in patients with progressive MS treated with cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Total brain N-acetylaspartate: a new measure of disease load in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

A serial study of new MS lesions and the white matter from which they arise

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Correlates of MS disability assessed in vivo using aggregates of MR quantities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Whole-brain diffusion MR histograms differ between MS subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Diagnostic criteria for primary progressive multiple sclerosis: a position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Chemical pathology of acute demyelinating lesions and its correlation with disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Reversible decreases in N-acetylaspartate after acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Magnetization transfer ratio changes in a symptomatic lesion of a patient at presentation with possible multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Diffusion tensor magnetic resonance imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

Weekly diffusion-weighted imaging of normal-appearing white matter in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00210.X

10.1046/J.1468-1331.2001.00210.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference